Solasia Pharma K.K.
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
Solasia Pharma K.K. made a loss over the last year. Solasia Pharma K.K. owes ¥0.23 for every ¥1 it owns. Solasia Pharma K.K. made a loss in each of the last two years.
Compared with Healthcare companies in Japan · latest annual results Dec 2025.
P/E ratio
LossSolasia Pharma K.K. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
5.26The share price is 5.26 times Solasia Pharma K.K.'s book value per share, higher than 89% of Healthcare companies in Japan.
Market cap
¥7.6 BThe total market value of all of Solasia Pharma K.K.'s shares at today's price (share price × number of shares), smaller than 67% of Healthcare companies in Japan. PosiCap size class: Micro Cap.
Net worth (book value)
¥1.5 BWhat Solasia Pharma K.K. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
¥5.32Net worth divided by the number of shares. The share price of ¥28.00 is 5.3 times this, which is the P/B above.
Return on equity (ROE)
-66.0%Solasia Pharma K.K. lost 66.0% of its shareholders' money over the last year, lower than 91% of Healthcare companies in Japan.
Owes vs Owns
0.23×Solasia Pharma K.K. owes ¥0.23 for every ¥1 it owns (low), lower than 71% of Healthcare companies in Japan.
Dividend yield
NoneSolasia Pharma K.K. does not currently pay a dividend.
Revenue growth
+36%Revenue rose 36% in the year to Dec 2025, and shrank 27% a year on average over 3 years.
Profit growth
LossSolasia Pharma K.K. made a loss in each of the last two years.
Profit margin
-204.2%Solasia Pharma K.K. lost ¥204 for every ¥100 of revenue.
Interest cover
Not coveredSolasia Pharma K.K.'s operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net cashSolasia Pharma K.K. held ¥1.4 B more cash than debt (net cash) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Solasia Pharma K.K.: ¥7.6 B ÷ ¥1.5 B (30 Jun 2026) = 5.3.
What is Solasia Pharma K.K.'s return on equity?
Solasia Pharma K.K. lost 66.0% of its shareholders' money over the last year, lower than 91% of Healthcare companies in Japan.
How much does Solasia Pharma K.K. owe compared with what it owns?
Solasia Pharma K.K. owes ¥0.23 for every ¥1 it owns (low), lower than 71% of Healthcare companies in Japan.
Does Solasia Pharma K.K. pay a dividend?
No. Solasia Pharma K.K. does not currently pay a dividend.
Is Solasia Pharma K.K.'s revenue growing?
Revenue rose 36% in the year to Dec 2025, and shrank 27% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.